Resilience (Healthtech) Stock
HealthTechLooking to sell Resilience (Healthtech) stock or options?
Resilience (Healthtech) operates as an advanced biopharmaceutical manufacturing company aiming to revolutionize medicine production. The company provides a comprehensive array of tailored manufacturing solutions designed to meet the needs of biopharmaceuticals throughout the entire drug development lifecycle, from pre-clinical development to commercial supply. By offering clients customized and scalable processes, Resilience ensures high-quality production and regulatory compliance, along with facilities equipped to handle complex and innovative medicines.
GV, Pfizer Ventures, Rsquared, AIM13 CV Partners, Koch Disruptive Technologies, Catalio Capital Management, Echo Investment Capital, Global Health Investment Corporation, New Enterprise Associates, Applied Ventures, Government of Canada, Public Sector Pension Investment Board, U.S. Department of Health and Human Services, 8VC, ARCH Venture Partners, Mubadala Investment Company, Dragoneer Investment Group, Raptor Group, Casdin Capital, Magnetic Ventures, Jameel Investment Management Company, Lux Capital.